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Hyaluronan (HA), a polymeric 
glycosaminoglycan ubiquitously present in 
higher animals is hydrolyzed by hyaluronidases 
(HAases). Here we used bee HAase as a model 
enzyme to study HA-HAase interaction. 
Located in close proximity to the active center, 
a bulky surface loop, which appears to obstruct 
one end of the substrate binding groove, was 
found to be functionally involved in HA 
turnover. To better apprehend kinetic changes 
in substrate interaction, binding of high 
molecular weight HA to catalytically inactive 
HAase was monitored by means of Quartz 
Crystal Microbalance technology. Replacement 
of the delimiting loop by a tetrapeptide 
interconnection increased the affinity for HA 
up to 100-fold, with a KD below 1 nM being the 
highest affinity amongst HA-binding proteins 
surveyed so far. 
The experimental data of HA-HAase 
interaction were further validated showing best 
fit to the theoretically proposed sequential two-
site model. Besides the one, which had been 
shown previously in course of X-ray structure 
determination, a previously unrecognized 
binding site works in conjunction with an 
unbinding loop that facilitates liberation of 
hydrolyzed HA. 
 
Hyaluronan (HA) is an unbranched 
glycosaminoglycan, which is composed of 
repeating disaccharide units of D-glucuronic acid 
and N-acetyl-D-glucosamine, and functional roles 
thereof are specifically related to its polymeric 
size (1). The shape and function of many 
anatomical structures in higher organism depend 
on high molecular weight HA as a ubiquitously 
present extracellular matrix determinant (2). 
Moreover, long HA chains also effectively 
modulate immune processes (3,4), while 
oligomeric HA stimulates angiogenesis (5), excites 
the synthesis of inflammatory cytokines (6), 
induces heat shock proteins and suppresses 
apoptosis (7). The respective polymeric size is 
thought to be the result of the balancing action of 
HA synthases (8) and hyaluronidases (HAase) 
(9,10), the latter being primarily responsible for 
HA degradation. 
The HAase isolated from the venom gland of 
honey bee (bee venom HAase, or BVH) was the 
first HAase member of the endo-β-N-acetyl-
hexosaminidase family (EC 3.2.1.35), to which 
also all human HAases belong, that could be 
molecularly cloned and recombinantly expressed 
(11). BVH is an endoglycolytic enzyme which 
catalyzes the hydrolysis of β-1,4 glycosidic bond 
of HA, as well as although with consistently lesser 
efficiency, chondroitin sulfates (12). In case of HA 
hydrolysis, the reducing end is generated at the 
terminal N-acetyl-D-glucosamine.  
Many structural features of BVH are also present 
in human HAases such as HYAL1 (13) or HYAL2 
(14). The 3-dimensional structure of BVH could 
be elucidated by means of X-ray crystallography 
(15). Moreover, the exact positioning of a HA 
tetramer tethered directly adjacent to the active 
center could be resolved. This data greatly argued 
for an acid/base catalytic mechanism, in which 
glutamic acid acts as the proton donor and the N-
acetyl carbonyl group of the substrate as the 
nucleophilic base (16). The presence of an 
extended furrow spanning one hemisphere of the 
globular structure of the bee enzyme further 
suggested that long parts of the HA chain interact 
also with sites other than that next to the active 
centre. 
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In this study, we used BVH as a model enzyme, 
primarily because we could recently establish 
methods for high-yield recombinant expression in 
Pichia pastoris (12). We also wanted to 
investigate the function of a bulky structure 
delimiting one end of the putative substrate 
binding groove in acid-active HYAL-1, and as 
recently shown by us to be involved in regulating 
this enzyme’s activity with respect to varying pH 
(17). Whether structural determinants in the close 
vicinity to this particular structure are actually 
involved in regulating substrate binding, or solely 
influence the active centre by long distance 
conformational changes remained elusive. 
To address this question experimentally, we 
performed extensive kinetic analysis with wild-
type recombinant BVH, as well as with a variant 
lacking the bulky formation. The results obtained 
suggest a likely role in substrate binding for the 
region next to the bulky formation. Working along 
this line we were able to reveal distinct kinetic 
parameters of substrate binding employing quartz 
crystal microbalance (QCM) technology (18,19). 
All results taken together, the presence of a second 
binding site could be demonstrated at that end of 
the substrate binding groove’s opposite at the face 
of the bulky formation. This site probably controls 
product release. 
 
EXPERIMENTAL PROCEDURES 
 
Materials 
Hyaluronic acid potassium salt from human 
umbilical cord with an estimated average 
molecular mass of 750 kDa (H1504, lot 
097K1495), chondroitin sulfate-A (27042, lot 
STBC0183V) with an estimated average 
molecular mass of 21 kDa (20,21), chondroitin 
sulfate-B (C3788, lot 080M1668V) of about  42 
kDa (21), chondroitin sulfate-C (C4384, lot 
1426300V) of about 60 kDa (22), N-acetyl-
glucosamine (A8625), potassium tetraborate 
tetrahydrate (P5754), p-dimethyl-benzaldehyde 
(D2004) were purchased from Sigma. 
 
Molecular modeling 
The three dimensional structure of BVH has 
recently been deciphered in the presence of a HA 
tetrasaccharide by others (15). 3D-structural 
models of BVH isoforms and active centre 
variants were visualized using the open-source 
PyMol 1.1eval software (DeLano Scientific LLC) 
and further evaluated with the aid of the QMEAN 
method of SWISS-MODEL software 
(swissmodel.expasy.org) on the basis of 
coordinates for BVH in conjunction with a HA 
tetrasaccharide (PDB accession code, 1fcv) to 
validate the degree of nativeness of the BVH 
isoforms compared to the wildtype structure (23).  
 
Mutagenesis of hyaluronidase 
Numbering of the amino acids of BVH starts with 
Thr in its mature form (15). An inactive variant of 
BVH named NQ-BVHWT was obtained by 
mutation of both amino acids in the active centre, 
D111N and E113Q (24). The respective cDNAs 
were inserted into the yeast expression vector, 
pPIC9 in frame with the α-factor signal sequence 
and under the control of AOX1 promoter using 
restriction sites EcoRI and NotI, respectively. 
Four-primer PCR technology was used to replace 
a 11-amino acid stretch, which loops out between 
the two cysteine residues at position 189 and 201 
by the tetrapeptide GSGS. The mutagenesis 
primers were the following (the mutated 
nucleotides are underlined): forward 5’-
TTCGCAGGAGCCACTACCGCAATAAGGGT
AGGC-3’ and reverse 5’-TATTGCGGTAGTGG 
CTCCTGCGAAGCGACCACC-3’. The resulting 
BVH variant was called BVHΔL. This cDNA was 
further modified by replacement with the 5’ 
terminal sequence of NQ-BVHWT using EcoRI and 
FseI endonuclease yielding a cDNA encoding for 
the inactive isoform NQ-BVHΔL. All sequences 
were validated by sequencing. 
 
Recombinant hyaluronidase expression and 
purification 
BVH variants were expressed in Pichia pastoris. 
The pPIC9 plasmid containing either wild-type or 
mutated cDNA was linearized by SalI digestion 
and electrotransformed into GS115 strain. After 
methanol-induction of recombinant Pichia strains, 
high-yields of secreted BVH variants was found in 
the growth medium. The cells were removed by 
centrifugation, and the protein containing 
supernatant was filtered through a 0.45 µm filter 
and stored at -20°C for further use. 
Ion exchange chromatography was performed as 
described previously (12) with minor 
modifications. Briefly, the supernatant was diluted 
with 3 volumes of 50 mM Na-acetate pH 5.0 and 
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applied onto a cation exchange column (5 ml 
HiTrapTM SP HP, GE Healthcare) in a cold room. 
The bound enzyme was eluted by 50% salt 
gradient of 2 M NaCl and subsequently the pooled 
fractions were desalted on 5 ml HiTrapTM 
Desalting columns (GE Healthcare). 
 
Measurement of enzymatic activity 
Generation of reducing ends through the action of 
HAase was determined based on the method 
established by Reissig (25). High molecular 
weight HA (5 mg/ml), or as a standard, N-acetyl-
D-glucosamine were diluted to the desired 
concentration with 100 mM citrate buffer, pH 4.0 
containing 137 mM NaCl and 2.7 mM KCl in a 
total volume of 100 µl. The mixtures were 
prepared on ice, and after pre-incubation at 37°C 
the reaction was started by adding enzyme (15 
µg/ml of final concentration) diluted in the same 
buffer. The measurements were performed at 37°C 
and the reaction was stopped by heat inactivation 
(95°C, 3 min). Thereafter, 20% (v/v) of 0.8 M 
tetraborate solution was added and the samples 
were heated again at 95°C for 3 min. After chilling 
on ice, 5 volumes of acetic acid containing 1% 
(w/v) p-dimethyl-benzaldehyde and 0.375% (w/v) 
HCl were added and the samples were incubated at 
37°C for 20 min. The optical density was 
measured by spectrophotometry at 585 nm. Four 
to six independent experiments were performed. 
One U of hyaluronidase activity is equal to the 
liberation of 100 nmol N-acetyl-D-glucosamine 
reducing ends generated by 1 mg enzyme. 
Endoglycolytic cleavage within polymeric HA 
produces two products, and thus doubles the 
substrate concentration. Yet the number of β-1,4 
glycolytic bonds available to the enzyme has 
actually decreased. Therefore, the number of 
cleavable β-1,4 linkages which also equals the 
number of disaccharide units of a polymeric HA 
chain was considered the basis for calculation of 
substrate concentration when building the kinetic 
model, also proposed previously elsewhere (26). 
Hence, the molar concentration of HA as a 
function of time is as follows: 
ሾܥ݄ሿ௧ ൌ ܣଵሺ1 െ ݁ି௞భ௧ሻ ൅ ܣଶሺ1 െ ݁ି௞మ௧ሻ 
 
 
k1 and k2 are rate constants for degradation and A1 
and A2 concentrations of specifically accessible β-
1,4 HA bonds for cleavage. The initial reaction 
rates were calculated as the values of the first 
derivative of the two exponentials at time zero. 
The Michaelis-Menten kinetic parameters could be 
calculated by non-linear regression of the data 
using KaleidaGraph 4.1.1 (Synergy Software, 
USA). 
 
Quartz crystal microbalance measurements 
Carboxyl sensor chips were obtained from Attana 
AB (Stockholm, Sweden). The preparation of the 
sensor chips and the immobilization procedure by 
amine coupling were performed according to the 
manufacturer’s instructions. Briefly, a carboxyl 
chip was pre-wetted with MilliQ water prior to the 
immobilization and was inserted in the Attana 
A100 QCM biosensor instrument (Attana AB, 
Stockholm, Sweden), and left to stabilize. The 
immobilization procedure was carried out at a 
flow rate of 10 µl/min in HBS-T buffer (10 mM 
HEPES, 150 mM NaCl, 0.005% Tween 20, pH 
7.4) at 25°C. Thereafter, 0.4 mM EDC and 0.1 
mM Sulfo-NHS were mixed in 1:1 ratio and the 
solution was injected immediately with 300 sec of 
contact time in order to activate the chip surface. 
After rinsing the injection loop with MilliQ water 
the ligand solution containing 20 or 10 µg/ml of 
purified NQ-BVHWT and NQ-BVHΔL, 
respectively, in 10 mM Na-acetate buffer, pH 5.0, 
was loaded to the chip for 300 sec. The injection 
loop was washed again with MilliQ water, and 
finally, the remaining activated carboxyl groups 
on the chip surface were neutralized by the 
injection of 1 M ethanolamine, pH 8.5 for 300 sec. 
For detecting background responses, a chip 
without protein was prepared following the same 
procedure. Substrate binding experiments were 
performed with a continuous flow (25 µl/min) of 
running buffer (20 mM citrate buffer, 137 mM 
NaCl, 2.7 mM KCl, 0.005% Tween 20, pH 4.0) 
allowing for a contact time of 100 sec. Substrate 
samples were prepared by serial dilutions in 
running buffer and the interaction was recorded 
with the aid of Attester® software (Attana AB, 
Stockholm, Sweden) for HA concentrations 
ranging from 0.05 to 1.0 mg/ml and for 
chondroitin sulfate concentrations ranging from 
0.05 to 0.5 mg/ml injected in a random order at 
37°C. After each measurement the chip surface 
was regenerated by a 30 sec injection of 2 M NaCl 
to remove any remaining analyte. Two to three 
independent experiments were performed. 
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The frequency response curves of the interaction 
between the various substrates at different 
concentrations and the immobilized inactive BVH 
variants, as well as the unmodified surface were 
analyzed by the Attache Evaluation software, 
version 3.3.3.1 (Attana AB, Stockholm, Sweden). 
The curves obtained at distinct substrate 
concentrations were averaged and corrected by 
subtracting the non-specific binding responses 
obtained from measurements using unmodified 
surface. The kinetic data analysis was performed 
using ClampXP2 3.50 provided by the developers 
(27), by fitting theoretical models to the 
experimental data. First, a global analysis attempt 
was made, which proved insufficient. Next, a local 
analysis of the association and the dissociation 
phases was performed. The equilibrium 
dissociation constants of BVH variants for high 
molecular weight HA and chondroitin sulfates 
were calculated from the directly estimated 
association and dissociation rate constants 
(KD=kdiss/kass). 
 
RESULTS 
 
Enzyme activity and kinetic analysis 
The substrate binding groove of HAase is 
constrained at one end by a bulky noose, which 
comprises a short stretch of amino acids that loop 
out at a cystine bridge linking position 189 and 
201. By means of computer-aided homology 
modeling (23), this loop could be replaced by the 
tetrapeptide GSGS, which yielded the enzyme 
variant BVHΔL (Figure 1A). When expressed in 
Pichia pastoris, both the wild-type and the mutant 
form were secreted into the growth medium, from 
where large quantities of active enzyme could be 
purified (Figure 1B). Compared to wild-type, 
BVHΔL exhibited lower specific activity, and 
although both HAases were active throughout a 
wide pH range, BVHΔL was found inactive above 
pH 7.0. For subsequent substrate binding studies, 
also inactive isoforms of both BVHWT and BVHΔL 
were generated by substituting the two essential 
acidic residues of the active centre. The resulting 
mutants D111N/E113Q-BVHWT and 
D111N/E113Q-BVHΔL were named NQ-BVHWT 
and NQ-BVHΔL; both mutant isoforms lacked any 
detectable HAase activity (data not shown). 
Turnover rates were assessed by monitoring the 
formation of reducing ends during HA 
depolymerization. As both BVHWT and BVHΔL 
exhibited highest activities between pH 3.0 and pH 
5.5 (Figure 1B), kinetic analyses were performed 
at pH 4.0. Both variants showed a progressive 
decrease of reaction rates at substrate 
concentrations up to 2 mg/ml. The best fit for all 
series of experimental data points was a 
biexponential function, displaying two distinct 
phases of a putative two-step process: during the 
early phase, the number of reducing ends increases 
rapidly, high molecular weight HA is efficiently 
hydrolyzed and a large amount of oligomeric 
substrate is generated; thereafter reaction rates 
gradually decrease. Even in the presence of high 
HA concentrations, BVHWT could always reach 
this late phase. In contrast, BVHΔL showed 
reduced hydrolysis rates during the early stage, 
and kinetics only approached the late phase during 
the time-course of the experiment at low HA 
concentrations (Figure 2). 
Next, the initial reaction rates were calculated and 
plotted against HA concentration. The kinetic 
curves clearly showed that hydrolysis rates 
gradually decreased at HA concentration higher 
than 0.5 mg/ml for BVHWT, or 0.2 mg/ml for 
BVHΔL. Consequently, the initial reaction rates 
showed asymmetric, bell-shaped concentration 
dependencies with optima between 0.2-0.5 mg/ml 
HA for the wild-type enzyme (Figure 3A). Despite 
displaying similar characteristics, the initial rate of 
BVHΔL was found to be 10-times lower (Figure 
3B). 
The biexponential progression of HA hydrolysis 
could be resolved into two kinetic phases: a 
dominant fast-rate step (v01) and a slow process 
with a distinctly lower rate (v02). Both the wild-
type and the mutant enzyme have comparable v02; 
the 10-fold difference in v0 is largely due to a rate 
difference of the dominant reaction v01 (Figure 3). 
At the early phase of the reaction solely high 
molecular weight HA is present, which is 
degraded by the wild-type enzyme with high v01. 
This suggests that the turnover rate of long chains 
appears to be enhanced through the action of the 
bulky loop, be it through long-distance 
conformational changes of the active centre or 
modulated through influencing substrate binding. 
Next, Vmax and Km of the hydrolysis reaction were 
estimated by performing curve fitting of the 
ascending and descending phases of the initial rate 
progress. The Vmax for BVHWT was 1·106 ± 3·104, 
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and that of BVHΔL converged to 1.3·105 ± 2·103 
U/min. Unexpectedly, BVHΔL had a lower Km 
compared to BVHWT (0.24 ± 0.01 vs. 0.37 ± 0.08 
mg/ml), indicative for higher substrate affinity. 
 
Substrate binding 
Under the experimental conditions used in the 
previous kinetic analyses, substrate degradation 
rates of BVH and the loop variant were too high 
for binding studies. Therefore, interactions at 
varying HA concentrations (0.05 – 1 mg/ml) were 
studied with the inactive HAase variants NQ-
BVHWT and NQ-BVHΔL. Both HAase variants 
firmly bound high molecular weight HA. The 
point mutations introduced in the active centre, 
although located within the substrate binding 
groove did not induce major conformational 
changes, which incommode HA binding. 
Moreover, the polymer could be detached from 
both variants. Prior to a successive measurement 
the chip was efficiently regenerated by washes 
with high ionic strength buffer (Figure 4). 
Working along these lines experimental data for 
HA association to and dissociation from the 
inactive HAase variants were collected. The 
results obtained thereby were further validated 
using previously established theoretical models. A 
fit to the simple Langmuir binding model could 
not be accomplished, both the simple binding, as 
well as the mass transport-limited models were 
unable to adequately describe the interaction. This 
suggested that interactions between HA and BVH 
are more complex. Therefore various two-state 
models were challenged (28-30) and finally, a 
two-site model was computed, which provided 
useful fits. When supposing substrate binding in 
random order the estimation of two out of four 
association rate constants (kass) yielded no 
meaningful results, suggesting that distinct binding 
events are either negligible or random 
combinations of binding and unbinding are likely 
circumstantial. Challenging the alternative 
proposition that binding may take place in a 
directed fashion the following sequential two-site 
mode  l was fitted:
ܵ1 ൅ ܪܣ ֖ ܵ1. ܪܣ ൅ ܵ2 ֖ ܵ1. ܪܣ. ܵ2  
 
 
S1 and S2 are putative substrate binding sites, and 
thus this model assumed that the enzyme actually 
accommodates two distinct binding sites, which 
associate with the polymer in a sequential order. 
Also, this particular model approximated the 
experimental data regarding the interaction of HA 
with the two inactive variants best, as the kinetics 
showed congruent matches for all experimental 
data sets (Figure 4). Since the global fitting 
algorithm could not be applied, the association 
(kass) and dissociation (kdiss) constants, as well as 
the equilibrium dissociation constants (KD) were 
determined for each HA concentration by local 
fitting (Table 1). 
When plotting kass and kdiss rate constants of the 
two binding sites against substrate concentration, 
it became apparent that when comparing the 
derived data to that of the wild-type enzyme, the 
inactive loop variant, NQ-BVHΔL formed the HA-
enzyme complex at a considerably higher rate as 
reflected by a higher kass, at the second binding site. 
Moreover, HA was released more slowly from the 
complex as kdiss at the second binding site was 
distinctly lower. In either variant, kass and kdiss of 
the first binding site were found comparable thus 
indicating that the putative second binding site is 
locally close to the bulky loop (Figure 5A and B). 
Also line-up of the KDs regarding the first binding 
sites (KD1) showed highly similar results for both 
variants, with a sole exception of a slight 
difference at the highest experimental HA 
concentration. In the case of NQ-BVHΔL, the 
second binding site exhibited again a significantly 
lower KD2 (Figure 5C), by and large confirming 
the aforementioned assumption that the bulky 
formation solely impinges on the putative second 
binding site, which when not affected by the loop 
has high HA affinity. 
Furthermore, comparison of the overall affinity 
constants (KDSUM) as calculated from the KD values 
of both binding site (KD1*KD2), revealed the 
highest value for the wild-type protein with 62.9 
nM at 0.5 mg/ml HA, whereas the loop variant 
exhibited 10 to 100-times lower KD values with a 
maximum value of 0.98 nM at 0.2 mg/ml HA 
concentration (Table 1). Thus, replacement of the 
bulky formation greatly enhanced the enzyme’s 
overall affinity for high molecular weight HA 
yielding tight binding and/or impeded product 
release. 
Chondroitin sulfate (CS) A, B, and C are also 
substrates to BVH. Compared to HA, the 
hydrolysis rate of CS-C is approximately 40%, for 
CS-C 20%, and CS-B is only very slowly 
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degraded (12). Binding of all three CS types to 
NQ-BVHWT, as well as to NQ-BVHΔL was 
evaluated accordingly (Supplemental Figures 1-
6,). Analysis of KDSUM for the CS types with 
regard to HA showed that substrate binding is an 
important actuating value determining turnover 
rates (Supplemental Table 1-3), as CS-B showed 
the highest KDSUM value of 801 nM at 0.5 mg/ml 
for the wild-type and 257 nM at 0.2 mg/ml for the 
loop variant (Supplemental Table 2), and CS-A 
and CS-C showed KDSUM values of 172 nM at 0.5 
mg/ml and 198 nM at 0.05 mg/ml for NQ-BVHWT, 
and 42.5 nM at 0.2 mg/ml and 19 nM at 0.1 mg/ml 
for NQ-BVHΔL, respectively. Further kinetic 
analyses showed best fit of the respective data 
again to the sequential two-site model. 
In view of these results we here propose a model 
for the cleavage cycle of HAase featuring two 
distinct binding sites, which sequentially bind and 
release the products accordingly (Figure 6). 
 
DISCUSSION 
 
The published crystal structures of HAases from 
bee (15) and wasp venom (31), or that of human 
serum HAase, HYAL-1 (32) led to the 
identification of a bulky knob, which rises at the 
upper end of the substrate binding groove. Both 
length and amino acid composition of this 
unshaped bump are highly variable, with the sole 
exception of a single asparagine residue which is 
conserved in most species. In many 
hyaluronidases from hymenoptera, that asparagine 
is part of a potential N-glycosylation recognition 
sequence, which in all cases characterized so far is 
followed by a proline. This combination however 
renders this particular site highly unlikely for 
posttranslational glycosylation (33). This 
assumption was further strengthened by 
comparing wild-type BVH with BVHΔL in which 
the respective stretch had been replaced with a 
tetrapeptide sequence comprising alternating Gly 
and Ser residues. The latter thus lacks the potential 
glycosylation site. After expression in Pichia 
pastoris, a microbe known to efficiently 
glycosylate, the molecular weight of the two 
secreted proteins was found comparable. 
Interestingly, enzymatic and kinetic analyses of 
BVHΔL in which the blocking knob has been 
depleted showed that it has reduced activities. 
Previous analyses with bovine testicular 
hyaluronidase had shown that two phases of HA 
hydrolysis can be distinguished: an early part, 
where high-molecular-weight HA was found to be 
degraded at a relatively fast rate; thereafter the 
resulting oligomeric fragments were hydrolyzed 
with slow kinetics (26,34,35). This was found to 
be true for wild-type BVH activity. However, the 
results obtained for BVHΔL which supposedly 
should offer more open space for a high molecular 
weight substrate, were unexpected. The rapid early 
phase of HA hydrolysis was not found for the 
enzyme variant. Although counterintuitive, this 
bulky loop actually enhances turnover of 
polymeric HA. 
The initial reaction rates for both wild-type and 
BVHΔL clearly showed an inhibition at high HA 
concentration. As previously reported, short HA 
fragments are poor substrates for HAases (34,35). 
Provided that the atypical bell-shaped progression 
of the substrate concentration dependence could be 
due to increasing amounts of short HA oligomers 
in concentrated polydispers substrate solutions. 
Increasing concentrations of short HA may thus 
shift to late phase kinetics and greatly decelerate 
the overall turnover rate. It is, however, also 
conceivable that similar to steric exclusion of 
bovine serum albumin in highly concentrated HA 
solutions (36,37) the observed suppression of 
enzyme activity could also be a consequence of 
crowding out of HAase by closely interacting HA 
chains. 
To address this open question, the kinetic data sets 
were analyzed further. Working along these lines 
yet only yielded the approximation of Michaelis-
Menten parameters. Still acceptable estimates for 
Vmax and Km could be achieved. An important 
result was that Km for BVHΔL was found to be 
much lower, thus indicating enhanced affinity for 
HA. 
More detailed binding studies were performed by 
means of QCM technology, which is capable of 
monitoring the interaction in real-time as a change 
in frequency of a surface coated quartz crystal 
resonator. In solution this method is highly 
effective at determining the affinity of molecules, 
in particular for large binding partners, such as 
high molecular weight HA. So far no experimental 
results based on QCM were available for HA-
HAase interaction. Surface Plasmon Resonance 
has previously been introduced to monitor the 
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interactions of bovine testicular hyaluronidase 
with sulfated glucosaminoglycans. Notably, 
however, HA as the major binding partner for 
HAase has for unknown reasons not been studied 
(38). 
When using enzymatically active HAase in QCM 
measurements, binding could be examined, but 
due to hydrolysis taking place at the same time 
with concomitant generation of highly polydispers 
HA, no distinct models for subsequent data 
analysis could be built. Stable interaction of HA, 
and other substrates such as CS with the enzyme 
could only be studied for HAase lacking 
hydrolysis activity. Mutations of specific catalytic 
residues in the active center were previously 
reported to inactivate human testicular 
hyaluronidase (24), as well as HYAL-1 (39). Point 
mutations introduced into BVH also yielded an 
inactive variant, which still bound high molecular 
weight substrate efficiently. From data obtained 
with this variant, a sequential two-site model could 
be deduced that features a dynamic mechanism 
involving a second potential binding site, which 
only becomes available after a first site has been 
successfully occupied by an uncleaved polymeric 
substrate. According to this model we propose the 
existence of two kinetically distinct binding sites, 
which are both located in the substrate binding 
groove on either side of the active center. 
Following the nomenclature for sugar binding sites 
in glycosyl hydrolases (40), the first binding site 
(S1) is at the –n subsites away from the non-
reducing end of cleaved HA, while the second 
binding site (S2), which we mapped next to the 
bulky formation interacts with HA at +n subsites, 
with cleavage taking place in between -1 and +1. 
The model of the cleavage cycle as depicted in 
Figure 6 states that initial attachment at S1 is 
mandatory for HA in order to subsequently 
interact with S2. After completion of the 
hydrolytic reaction the HA-fragment bound to S2 
will be released first and only thereafter the 
remaining fragment detaches from S1. 
Replacement of the loop yielded a variant with 
lower enzymatic activity but with up to 100-times 
higher affinity in HA-binding. The equilibrium 
dissociation constant, KD for high molecular 
weight HA was found to be 0.05 to 0.98 nM, while 
the KD for the wild-type enzyme was only 1.77 to 
62.9 nM. Previously reported KD for HA-binding 
proteins or hyalectins were 5-150 µM for CD44 
(41-43), 11-36 µM for LYVE-1 (43), 0.2-55 µM 
for TSG-6 (44,45), 226 nM for aggrecan and 
exactly 82 nM for Link protein (46). The HA 
receptor for endocytosis, HARE has the highest 
affinity for HA ranging 5 to 23 nM (47,48). 
Compared to these specific binding proteins, the 
BVH loop variant shows the highest avidity for 
HA. 
Indeed, the bulky formation interferes with HA 
binding, but probably promotes the unbinding of 
short oligomeric chains tethered to the +n site. The 
penultimate step of the catalytic cycle had actually 
been depicted before by X-ray structure 
determination of BVH co-crystallized with a HA-
hexasaccharide. In the crystals, the HA-
hexasaccharide had been degraded, and the HAase 
only retained a tetrasaccharide fragment bound to 
the subsites -4 to -1. At the –n subsites amino 
acids, which directly interact with HA such as 
Tyr55, Asp111, Glu113, Tyr184, Tyr227, Trp301, 
Ser303 and Ser304 could be identified (15). In 
turn, however, the situation regarding the +n 
subsites was less clear. To gain more insight, the 
3D coordinates of HA derived from the crystal 
structure of the BVH-HA complex were used for 
computational modeling studies placing a virtual 
HA chain all along into the binding groove of 
HYAL1. In this way amino acid residues located 
as close as 5 Å to the HA molecule could be 
identified. These were Asp129, Glu131, Tyr202, 
Tyr247, Ser245 and Arg265 (39). The latter two 
correspond to Ser225 and Arg244 of the bee 
enzyme. However, no direct interaction with the 
HA-tetrasaccharide had been reported in the 
previous study (15). Also in close vicinity to the 
bulky knob, Ser225 and Arg244 are likely residues 
of the +n subsites, and thus shaping the second 
binding site. 
In conclusion, we report here that the bulky 
formation, which at the first glance appears to 
block the substrate binding groove, actually 
contributes to a second HA binding site in HAase. 
The results presented in this study demonstrate 
that this loop is involved in modulation of the 
enzymatic activity, which besides substrate 
binding also requires efficient clearing of the 
products after catalytic processing. In turn, when a 
product is transiently retained at the second site 
through strong binding, further progression 
through the catalytic cycle is retarded. Through the 
bulky loop in BVH release of the cleaved HA 
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fragment from the enzyme is increased which 
results in a higher rate of hydrolysis. 
The various bulky formations in different 
hyaluronidase species may have evolved to 
efficiently hydrolyze high molecular weight HA in 
different biological processes. The bee venom 
enzyme is considered to be a spreading factor. At 
the site of a bee sting, rapid hydrolysis of HA 
chains in the dermis facilitates the diffusion of 
other venom constituents, mainly the lytic peptide 
mellitin and phospholipase, thereby augmenting 
local damage and inflammation. 
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FOOTNOTES 
 
The used abbreviations are: HA, hyaluronan; CS-A, chondroitin sulfate-A; CS-B, chondroitin sulfate-B; 
CS-C, chondroitin sulfate-C; BVH, bee venom hyaluronidase; HYAL-1, human serum hyaluronidase 1; 
QCM, Quartz Crystal Microbalance; PDB, protein database; AOX1, alcohol oxidase 1 
 
FIGURE LEGENDS 
 
FIGURE 1: 3D-models and enzymatic activity of the wild-type and the loop mutant of bee 
hyaluronidase 
The steric models of BVHWT (left) and BVHΔL (right) with a bound HA-tetrasaccharide (blue in stick 
mode) were generated using PyMol. The wild-type and the mutant loops are highlighted in yellow and 
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green, respectively, and the active centers, D111 and E113 are shown in magenta and red, respectively 
(Panel A). Expression of the wild-type enzyme and the variant were analyzed on a 12% SDS-PAGE and 
visualized by Coomassie-staining. The arrow indicates the expected molecular masses (inset in Panel B). 
Determination of pH dependence of BVHWT (● and solid line), and BVHΔL (■ and dashed line) using 0.1 
mg/ml of HA concentration and 20 min of incubation time at 37°C was performed by Reissig assay (n=3). 
The values represent the mean ± S.E. and in 80% of all data sets S.E. were <10%. The enzyme activity is 
expressed in Units (U), 1 Unit equaling 0.1 nmol of reducing N-acetyl-D-glucosamine end groups 
generated by 1 mg of enzyme (Panel B).  
 
FIGURE 2: Kinetics of HA hydrolysis at different substrate concentrations 
The time-course of HA hydrolysis of BVHWT (Panel A) and BVHΔL (Panel B) was detected by Reissig 
assay at pH 4.0 and at 0.05 (● and solid line), 0.1 (■ and dashed line), 0.2 (♦ and dotted line), 0.5 (▲ and 
solid line), 0.8 (▼ and dashed line), 1.0 (● and dotted line), 1.2 (■ and solid line) and 2.0 mg/ml (♦ and 
dashed line) of HA concentration at 37°C (n=4-6). The enzyme activity is expressed in Units (U). The 
values represent the mean ± S.E. and in 90% of all data sets S.E. were <15%. 
 
FIGURE 3: Substrate dependence of HA hydrolysis  
Initial reaction rates of BVHWT (● and solid line) on Panel A and BVHΔL (■ and dashed line) on Panel B 
at different HA concentrations were calculated from the biexponential parameters derived from the time-
course measurement. Decomposing the kinetic phases yielded a fast-rate reaction (v01, ▲ and dotted line) 
and a slow process (v02, ♦ and dotted line). The substrate progress curves were obtained by fitting the 
superposition of a saturated with an analogous displacement function. 
 
FIGURE 4: QCM sensorgrams for substrate binding 
Inactive forms of BVH containing the normal (Panel A) and the mutated loop sequences (Panel B) were 
used for QCM measurements. Varying HA concentrations (0.05 to 1.0 mg/ml) were loaded onto 
immobilized BVH in a random order and interactions were monitored at pH 4.0 and at 37°C (solid lines) 
(n=2-3). The curves from each HA concentrations were averaged and corrected by subtracting the non-
specific binding responses obtained from the unfunctionalized surface. The sequential two-site model was 
fitted (dotted lines) to the averaged sensorgrams by local analysis using ClampXP2 software. 
 
FIGURE 5: Comparison of the association and dissociation rate constants of HA-binding 
The association (kass) (Panel A) and the dissociation rate constants (kdiss) (Panel B) of the first (● and 
dotted line) and the second binding sites (● and solid line) of NQ-BVHWT and the first (■ and dotted line) 
and the second binding sites (■ and solid line) of NQ-BVHΔL were estimated directly during the fitting 
procedure. The KD values of the first (● and dotted line) and the second binding sites (● and solid line) of 
NQ-BVHWT and the first (■ and dotted line) and the second binding sites (■ and solid line) of NQ-BVHΔL 
were calculated from the association and the dissociation constants (KD=kdiss/kass) (Panel C). Values 
represent the mean ± S.E. and in 78% of all data sets S.E. were <25%. 
 
FIGURE 6: Cleavage cycle of bee hyaluronidase 
The schematic representation of the model for the cleavage cycle was built-up based on HA-binding and 
hydrolysis data. HA sugar residues are drawn according to commonly accepted graphical carbohydrate 
symbolism (49); N-acetyl-D-glucosamine is depicted as a  black square with black lines and D-glucuronic 
acid as a diamond with grey upper segment and black outline. Reducing ends of the substrate are 
indicated by R, non-reducing ends by N; in hydrolysis products R’ and N’ is used accordingly. 
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TABLE 1: Kinetic parameters of HA-binding determined by QCM approach 
The kinetic data was evaluated using a two-state (sequential two-site) model and the kinetic parameters (mean ± SE) were calculated based on the 
average molecular mass of 750 kDa for HA. 
 INTERACTION 
PHASE 
KINETIC 
PARAMETER 
HA concentration (mg/ml) 
 0.05 0.1 0.2 0.5 1.0 
N
Q
-
B
V
H
W
T
 
EQUILIBRIUM 
KD1 (x 10-8) 
(M) 
3.22 ± 0.12 3.05 ± 0.32 2.48 ± 0.16 9.84 ± 0.61 87.7 ± 2.76 
KD2 (x 10-2) 5.48 ± 1.13 12.0 ± 3.70 52.0 ± 8.71 64.0 ± 17.6 0.69 ± 0.35 
KDSUM (x 10-9) 1.77 ± 0.43 3.66 ± 1.51 12.9 ± 3.00 62.9 ± 21.1 6.10 ± 3.26 
ASSOCIATION 
kass1 (x 104)        
(M-1·s-1) 
66.7 ± 1.52 99.2 ± 4.72 106 ± 2.69 18.5 ± 0.39 3.34 ± 0.04 
kass2 (x 10-3) 54.9 ± 4.95 13.5 ± 1.89 2.64 ± 0.24 0.78 ± 0.14 8.62 ± 0.31 
kassSUM (x 103) 36.6 ± 4.14 13.4 ± 2.51 2.80 ± 0.33 0.14 ± 0.03 0.29 ± 0.01 
DISSOCIATION 
kdiss1 (x 10-3)       
(s-1) 
21.5 ± 0.34 30.3 ± 1.72 26.3 ± 1.04 18.2 ± 0.74 29.3 ± 0.57 
kdiss2 (x 10-4)   30.1 ± 3.50 16.5 ± 2.78 13.7 ± 1.05 5.06 ± 0.48 0.00(a) ± 0.28 
kdissSUM (x 10-6) 64.7 ± 8.55 50.0 ± 11.3 36.0 ± 4.19 9.21 ± 1.25 1.76 ± 0.85 
N
Q
-
B
V
H
Δ
L
 
EQUILIBRIUM 
KD1 (x 10-8) 
(M) 
2.40 ± 0.27 4.69 ± 0.49 2.59 ± 0.29 6.34 ± 0.55 12.5 ± 6.63 
KD2 (x 10-2) 0.48 ± 0.09 0.91 ± 0.54 3.80 ± 1.03 1.11 ± 0.59 0.04 ± 0.03 
KDSUM (x 10-9) 0.11 ± 0.03 0.42 ± 0.29 0.98 ± 0.37 0.70 ± 0.44 0.05 ± 0.07 
ASSOCIATION 
kass1 (x 104)        
(M-1·s-1) 
108 ± 9.06 78.3 ± 2.37 80.9 ± 2.55 37.3 ± 0.77 23.2 ± 10.3 
kass2 (x 10-3) 62.0 ± 2.02 42.4 ± 15.4 9.21 ± 0.58 5.41 ± 0.27 150 ± 30.9 
kassSUM (x 103) 67.0 ± 7.80 33.2 ± 13.1 7.45 ± 0.70 2.01 ± 0.14 34.8 ± 22.6 
DISSOCIATION 
kdiss1 (x 10-3)       
(s-1) 
25.9 ± 0.69 36.7 ± 2.72 20.9 ± 1.65 23.6 ± 1.58 29.0 ± 2.51 
kdiss2 (x 10-4)   2.99 ± 0.48 3.84 ± 0.89 3.50 ± 0.73 0.00(a) ± 0.29  0.00(a) ± 0.37 
kdissSUM (x 10-6) 7.74 ± 1.45        14.1 ± 4.31 7.32 ± 2.10 1.42 ± 0.78 1.74 ± 1.22 
 
(a) ClampXP2 cannot calculate kdiss values under 10-4, therefore instead of zero, an estimated value, 0.6·10-4 was substituted.  
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